MURRAY RICHARD /CA/ 4
4 · Jounce Therapeutics, Inc. · Filed Jan 11, 2023
Insider Transaction Report
Form 4
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
- Sale
Common Stock
2023-01-10$1.12/sh−24,879$27,864→ 228,007 total - Sale
Common Stock
2023-01-09$1.10/sh−20,191$22,210→ 252,886 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]Represents the weighted average share price of an aggregate total of 20,191 shares sold in the price range of $1.03 to $1.17 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 24,879 shares sold in the price range of $1.05 to $1.15 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission Staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.